Latest News from Gb Sciences

Gb Sciences Co-Publishes Study Demonstrating Efficacy of Its Proprietary Cannabinoid Mixtures for the Treatment of Parkinson’s Disease

Gb Sciences Granted U.S. Patent for Cannabinoid-Containing Treatment for Advanced Heart Disease, TRPV1-Receptor-Associated Hearing Loss and Urinary Cystitis

Gb Sciences to Begin Dosage Study for Its Novel Parkinson’s Disease Formulations at the University of Lethbridge

As seen on Worldwide Business with Kathy Ireland

Choose Your Area Of Interest


GBLX’s novel drug discovery program produced 6 issued US and 3 issued international patents, as well as 17 US and 51 international patent-pending applications. We have 5 preclinical phase drug programs in our pipeline, and our Parkinson’s therapeutics are being prepared for a First-in-Man trial.

Learn More


The strength of our R & D pipeline has been the participation of world class researchers from 9 international universities over the past 7 years. Together, we have assembled the ultimate toolkit to create the future of medicine; AI technology, plant-based medicine, and hard sciences.

Learn More


Translating new drug principles into real world medicines requires expertise in several disciplines. Our partners help make our dream of novel plant-inspired medicines a reality by providing expertise in cGMP-certified active ingredients and novel oral delivery methods.

Learn More


Our Goal is to preserve the efficacy of plant-based medicines while reducing their complexity for standardization.

Our Strategy is to combine our proprietary PhAROS Drug Discovery Platform and High Throughput Screening of Cell and Animal Models of Specific Disease Processes to Create Rationally-Designed, Minimum Essential Mixtures.

Here are the latest articles
by Gb Sciences.

Navigating the COVID-19 Pandemic: A Novel Cannabinoid-Based Treatment Strategy

Pharma’s Almanac: Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures

University of Lethbridge researching possible Parkinson’s disease treatments

Here are the latest podcasts
by Gb Sciences.

Terpenes and Testing

DocWire Podcast: Dr. Andrea Small-Howard, Gb Sciences, Talks Plant-Based Therapies for Parkinson's Disease

IDC Podcast: Bringing Medicines to Market Faster Through Analytics & Machine Learning